| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.04B | +32.1% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.04B | — |
| Net income | ¥-0.03B | — |
| Gross margin | 29.5% | Net margin -69.6% |
| Revenue Q/Q | -89.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.03B | 70.5% |
| R&D | ¥0.03B | 84.5% |
| SG&A | ¥0.02B | 50.4% |
| Tax & other | ¥-0.01B | -35.8% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
尚水智能 ・ 港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份 ・ 万邦医药 ・ 上大股份 ・ 儒竞科技 ・ 国际复材 ・ 多浦乐 ・ 福赛科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies